Cargando…

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours

BACKGROUND: It is well known that sarcopenia is a common risk factor in patients with gastrointestinal tumours, which may negatively affect the clinical outcome and prognosis. Recent studies suggest that serum creatinine-cystatin C (Cr/CysC) ratio may be associated with sarcopenia, but this associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Ping’an, Guo, Honghai, Sun, Chenyu, Chen, Shuya, Yang, Peigang, Tian, Yuan, Lowe, Scott, Zhao, Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Nutrition
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478187/ https://www.ncbi.nlm.nih.gov/pubmed/36118766 http://dx.doi.org/10.3389/fnut.2022.963265

Ejemplares similares

Combined systemic inflammatory immunity index and prognostic nutritional index scores as a screening marker for sarcopenia in patients with locally advanced gastric cancer
por: Ding, Ping'an, et al.
Publicado: (2022)

Relationship Between Nutritional Status and Clinical Outcome in Patients With Gastrointestinal Stromal Tumor After Surgical Resection
por: Ding, Ping'an, et al.
Publicado: (2022)

Sarcopenia: Molecular regulatory network for loss of muscle mass and function
por: Wu, Jiaxiang, et al.
Publicado: (2023)

A Novel Application of Serum Creatinine and Cystatin C to Predict Sarcopenia in Advanced CKD
por: Lin, Yu-Li, et al.
Publicado: (2022)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

Phase angle derived from bioelectrical impedance analysis as a marker for predicting sarcopenia
por: Wu, Haotian, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
por: Sun, Jing, et al.
Publicado: (2022)

Association Between the Nutritional Risk and the Survival Rate in Newly Diagnosed GIST Patients
por: Ding, Ping'an, et al.
Publicado: (2021)

Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease
por: Hyun, Young Youl, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
por: Fujita, Kohei, et al.
Publicado: (2022)

Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib
por: Ding, Ping’an, et al.
Publicado: (2023)

Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
por: Shi, Shanshan, et al.
Publicado: (2022)

Association between the ratio of serum creatinine to cystatin C and bone mineral density in Chinese older adults patients with type 2 diabetes mellitus
por: Gao, Ting, et al.
Publicado: (2022)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
por: An, Jung Nam, et al.
Publicado: (2022)

Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifan, et al.
Publicado: (2022)

MON-LB073 The Serum Creatinine to Serum Cystatin C Ratio Is a Reliable Surrogate Marker of Sarcopenia in Patients with Cushing's Syndrome in Remission
por: Martel, Luciana, et al.
Publicado: (2019)

Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifang, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
por: Zheng, Chao, et al.
Publicado: (2022)

Impact of skeletal muscle loss during conversion therapy on clinical outcomes in lavage cytology positive patients with gastric cancer
por: Ding, Ping’an, et al.
Publicado: (2022)

Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk/Malnutrition and Sarcopenia in Older Patients
por: Ren, Chenxi, et al.
Publicado: (2022)

Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
por: Yoshii, Ichiro, et al.
Publicado: (2023)

Diagnostic Value of Serum Creatinine and Cystatin-C-Based Indices and Ishii Score in Cancer-Related Sarcopenia
por: Ding, Liming, et al.
Publicado: (2023)

Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injury
por: İnal, Salih, et al.
Publicado: (2014)

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
por: Gao, Shunhui, et al.
Publicado: (2023)

Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients
por: Tang, Tianjiao, et al.
Publicado: (2020)

Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer
por: Tang, Tianjiao, et al.
Publicado: (2022)

In silico investigation of molecular networks linking gastrointestinal diseases, malnutrition, and sarcopenia
por: Hoch, Matti, et al.
Publicado: (2022)

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease
por: Li, Shaobo, et al.
Publicado: (2021)

Predictive Effect of Systemic Immune-Inflammation Index Combined With Prognostic Nutrition Index Score on Efficacy and Prognosis of Neoadjuvant Intraperitoneal and Systemic Paclitaxel Combined With Apatinib Conversion Therapy in Gastric Cancer Patients With Positive Peritoneal Lavage Cytology: A Prospective Study
por: Ding, Ping’an, et al.
Publicado: (2022)

Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study
por: Jung, Chan‐Young, et al.
Publicado: (2022)

Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2022)

Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China
por: Zhu, Yueli, et al.
Publicado: (2022)

The serum creatinine to cystatin C ratio predicts the risk of acute exacerbation of chronic obstructive pulmonary disease
por: He, Liang, et al.
Publicado: (2023)

Serum-Creatinine-to-Cystatin C-to-Waist-Circumference Ratios as an Indicator of Severe Airflow Limitation in Older Adults
por: Li, Jinxuan, et al.
Publicado: (2023)

Serum Cystatin C as a Marker of Renal Function in Critically Ill Patients With Normal Serum Creatinine
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2014)

A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people
por: He, Qian, et al.
Publicado: (2018)

Serum creatinine as an indicator of lean body mass in vegetarians and omnivores
por: Bartholomae, Eric, et al.
Publicado: (2022)

Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia
por: Kusunoki, Hiroshi, et al.
Publicado: (2020)

Sarcopenia index based on serum creatinine and cystatin C predicts the risk of postoperative complications following hip fracture surgery in older adults
por: Chen, Xiaoyan, et al.
Publicado: (2021)

Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5dmclh4rqphd2v2kfvumaorir5